Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis
Hilde Jenssen Bjørkekjær,
Cosimo Bruni,
Kaspar Broch,
Cathrine Brunborg,
Patricia E. Carreira,
Paolo Airò,
Carmen Pilar Simeón‐Aznar,
Marie‐Elise Truchetet,
Alessandro Giollo,
Alexandra Balbir‐Gurman,
Mickael Martin,
Christopher P. Denton,
Armando Gabrielli,
Francesco Del Galdo,
Madelon C. Vonk,
Håvard Fretheim,
Helle Bitter,
Øyvind Midtvedt,
Arne K. Andreassen,
Sverre Høie,
Yoshiya Tanaka,
Gabriela Riemekasten,
Ulf Müller‐Ladner,
Marco Matucci‐Cerinic,
Ivan Castellví,
E Arthritis and Rheumatology
· Wiley
· 2026-11-12
· DOI: 10.1002/art.70372
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Hilde Jenssen Bjørkekjær, Cosimo Bruni, Kaspar Broch, Cathrine Brunborg, Patricia E. Carreira, Paolo Airò et al. Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis. // Arthritis and Rheumatology. – 2026. – DOI: 10.1002/art.70372. – URL: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70372?af=R
Hilde Jenssen Bjørkekjær, Cosimo Bruni, Kaspar Broch, Cathrine Brunborg, Patricia E. Carreira, Paolo Airò, Carmen Pilar Simeón‐Aznar, Marie‐Elise Truchetet, Alessandro Giollo, Alexandra Balbir‐Gurman, Mickael Martin, Christopher P. Denton, Armando Gabrielli, Francesco Del Galdo, Madelon C. Vonk, Håvard Fretheim, Helle Bitter, Øyvind Midtvedt, Arne K. Andreassen, Sverre Høie, Yoshiya Tanaka, Gabriela Riemekasten, Ulf Müller‐Ladner, Marco Matucci‐Cerinic, Ivan Castellví, & E (2026). Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis. Arthritis and Rheumatology. https://doi.org/10.1002/art.70372
Hilde Jenssen Bjørkekjær, et al. “Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis.” Arthritis and Rheumatology, 2026. doi:10.1002/art.70372.
@article{Bjrkekjr2026,
title = {Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis},
author = {Bjørkekjær, Hilde Jenssen and Bruni, Cosimo and Broch, Kaspar and Brunborg, Cathrine and Carreira, Patricia E. and Airò, Paolo and Simeón‐Aznar, Carmen Pilar and Truchetet, Marie‐Elise and Giollo, Alessandro and Balbir‐Gurman, Alexandra and Martin, Mickael and Denton, Christopher P. and Gabrielli, Armando and Galdo, Francesco Del and Vonk, Madelon C. and Fretheim, Håvard and Bitter, Helle and Midtvedt, Øyvind and Andreassen, Arne K. and Høie, Sverre and Tanaka, Yoshiya and Riemekasten, Gabriela and Müller‐Ladner, Ulf and Matucci‐Cerinic, Marco and Castellví, Ivan and E},
journal = {Arthritis and Rheumatology},
year = {2026},
doi = {10.1002/art.70372},
url = {https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70372?af=R}
}
Mesenchymal stem cells (MSCs) have emerged as promising therapeutic agents in regenerative medicine, with their therapeutic effects increasingly attributed to intercellular communication and microenvironmental regulation rather than...
Background Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. Methods We analyzed GEO...
Background Lung cancer is one of the leading causes of cancer-related mortality worldwide. Understanding the molecular mechanisms underlying lung cancer progression is critical for identifying novel therapeutic targets. This study...